Health Care & Life Sciences » Pharmaceuticals | Biondvax Pharmaceuticals Ltd.

Biondvax Pharmaceuticals Ltd. ADR | Income Statement

Fiscal year is January-December. All values ILS Thousands.
2013
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
709.00
676.00
628.00
621.00
441.00
72.30
Gross Income
709.00
676.00
628.00
621.00
441.00
72.30
SG&A Expense
8,204.00
7,466.00
10,675.00
11,279.00
23,215.00
21,363.40
EBIT
8,913.00
8,142.00
11,303.00
11,900.00
23,656.00
21,435.70
Unusual Expense
297.00
4.00
564.00
2,964.00
7,969.00
558.80
Non Operating Income/Expense
1,038.00
298.00
553.00
276.00
2,871.00
230
Interest Expense
-
-
24.00
27.00
73.00
3,781.60
Pretax Income
8,036.00
7,764.00
10,199.00
9,184.00
34,551.00
24,400.70
Consolidated Net Income
8,036.00
7,764.00
10,199.00
9,184.00
34,551.00
24,400.70
Net Income
8,036.00
7,764.00
10,199.00
9,184.00
34,551.00
24,400.70
Net Income After Extraordinaries
8,036.00
7,764.00
10,199.00
9,184.00
34,551.00
24,400.70
Net Income Available to Common
8,036.00
7,764.00
10,199.00
9,184.00
34,551.00
24,400.70
EPS (Basic)
0.17
0.14
0.10
0.07
0.17
3.73
Basic Shares Outstanding
47,270.60
54,297.40
105,522.60
135,097.40
201,030.80
6,535.50
EPS (Diluted)
0.17
0.14
0.10
0.07
0.17
3.73
Diluted Shares Outstanding
47,270.60
54,297.40
105,522.60
135,097.40
201,030.80
6,535.50
EBITDA
8,204.00
7,466.00
10,675.00
11,279.00
23,215.00
21,363.40
Non-Operating Interest Income
136.00
76.00
11.00
55.00
18.00
27.80

About Biondvax Pharmaceuticals

View Profile
Address
Jerusalem BioPark
Jerusalem JM 74036
Israel
Employees -
Website http://www.biondvax.com
Updated 07/08/2019
BiondVax Pharmaceuticals Ltd. is a clinical stage biopharmaceutical company focused on developing and commercializing immunomodulation therapies for infectious diseases. It works on M-001, a synthetic peptide-based protein targeting both seasonal and pandemic strains of the influenza virus. The company was founded by Ron Babecoff and Rami Epstein on July 22, 2003 and is headquartered in Ness Ziona, Israel.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.